Follow
Katrine Bagge Hansen
Katrine Bagge Hansen
MD PhD
Verified email at dadlnet.dk
Title
Cited by
Cited by
Year
2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans
KB Hansen, MM Rosenkilde, FK Knop, N Wellner, TA Diep, JF Rehfeld, ...
The Journal of Clinical Endocrinology & Metabolism 96 (9), E1409-E1417, 2011
3082011
Effect of an intensive lifestyle intervention on glycemic control in patients with type 2 diabetes: a randomized clinical trial
MY Johansen, CS MacDonald, KB Hansen, K Karstoft, R Christensen, ...
Jama 318 (7), 637-646, 2017
2292017
Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects
KB Hansen, T Vilsbøll, JI Bagger, JJ Holst, FK Knop
The Journal of Clinical Endocrinology & Metabolism 95 (7), 3309-3317, 2010
1372010
The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans
MJ Mandøe, KB Hansen, B Hartmann, JF Rehfeld, JJ Holst, HS Hansen
The American journal of clinical nutrition 102 (3), 548-555, 2015
722015
Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes–a review
KB Hansen, T Vilsbøll, FK Knop
Diabetes, metabolic syndrome and obesity: targets and therapy, 155-163, 2010
712010
Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes–a review
KB Hansen, T Vilsbøll, FK Knop
Diabetes, metabolic syndrome and obesity: targets and therapy, 155-163, 2010
712010
Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects
KB Hansen, T Vilsbøll, JI Bagger, JJ Holst, FK Knop
The Journal of Clinical Endocrinology & Metabolism 97 (4), 1363-1370, 2012
642012
Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in …
KB Hansen, T Vilsbøll, JI Bagger, JJ Holst, FK Knop
The Journal of Clinical Endocrinology & Metabolism 96 (2), 447-453, 2011
632011
Treatment of type 2 diabetes with glucagon‐like peptide‐1 receptor agonists
KB Hansen, FK Knop, JJ Holst, T Vilsbøll
International journal of clinical practice 63 (8), 1154-1160, 2009
562009
Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial
M Ried‐Larsen, MY Johansen, CS MacDonald, KB Hansen, ...
Diabetes, Obesity and Metabolism 21 (10), 2257-2266, 2019
472019
Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding
L Usinger, KB Hansen, VB Kristiansen, S Larsen, JJ Holst, FK Knop
Obesity surgery 21, 625-632, 2011
402011
The influence of biogeographical and evolutionary histories on morphological trait‐matching and resource specialization in mutualistic hummingbird–plant networks
B Dalsgaard, PK Maruyama, J Sonne, K Hansen, TB Zanata, ...
Functional Ecology 35 (5), 1120-1133, 2021
382021
CropPol: A dynamic, open and global database on crop pollination
A Allen‐Perkins, A Magrach, M Dainese, LA Garibaldi, D Kleijn, R Rader, ...
Ecology 103 (3), e3614, 2022
302022
Head-to-head comparison of intensive lifestyle intervention (U-TURN) versus conventional multifactorial care in patients with type 2 diabetes: protocol and rationale for an …
M Ried-Larsen, R Christensen, KB Hansen, MY Johansen, M Pedersen, ...
BMJ open 5 (12), e009764, 2015
302015
Why prescribe exercise as therapy in type 2 diabetes? We have a pill for that!
M Ried‐Larsen, CS MacDonald, MY Johansen, KB Hansen, ...
Diabetes/metabolism research and reviews 34 (5), e2999, 2018
272018
Effects of an intensive lifestyle intervention on the underlying mechanisms of improved glycaemic control in individuals with type 2 diabetes: a secondary analysis of a …
MY Johansen, K Karstoft, CS MacDonald, KB Hansen, H Ellingsgaard, ...
Diabetologia 63, 2410-2422, 2020
262020
Determinants of fasting hyperglucagonemia in patients with type 2 diabetes and nondiabetic control subjects
M Demant, JI Bagger, MP Suppli, A Lund, M Gyldenløve, KB Hansen, ...
Metabolic Syndrome and Related Disorders 16 (10), 530-536, 2018
212018
Dose-response effects of exercise on glucose-lowering medications for type 2 diabetes: a secondary analysis of a randomized clinical trial
CS MacDonald, MY Johansen, SM Nielsen, R Christensen, KB Hansen, ...
Mayo Clinic Proceedings 95 (3), 488-503, 2020
192020
Effects of an exercise-based lifestyle intervention on systemic markers of oxidative stress and advanced glycation endproducts in persons with type 2 diabetes: Secondary …
GE Legaard, CS Feineis, MY Johansen, KB Hansen, AA Vaag, EL Larsen, ...
Free Radical Biology and Medicine 188, 328-336, 2022
182022
Once‐weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: real‐world data from a diabetes out‐patient clinic
KB Hansen, M Svendstrup, A Lund, FK Knop, T Vilsbøll, H Vestergaard
Diabetic Medicine 38 (10), e14655, 2021
152021
The system can't perform the operation now. Try again later.
Articles 1–20